Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Paraventricular Hypothalamic Nucleus | 14 | 2024 | 136 | 4.490 |
Why?
|
| Hypertension | 13 | 2023 | 1591 | 3.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 12 | 2023 | 265 | 2.950 |
Why?
|
| Excitatory Postsynaptic Potentials | 8 | 2024 | 251 | 1.840 |
Why?
|
| Neurons | 13 | 2024 | 2439 | 1.830 |
Why?
|
| Hypothalamus | 9 | 2023 | 272 | 1.720 |
Why?
|
| Receptors, AMPA | 2 | 2024 | 82 | 1.630 |
Why?
|
| Sympathetic Nervous System | 7 | 2023 | 159 | 1.310 |
Why?
|
| Calcineurin Inhibitors | 3 | 2024 | 67 | 1.280 |
Why?
|
| Tacrolimus | 3 | 2024 | 347 | 1.190 |
Why?
|
| Pituitary-Adrenal System | 2 | 2018 | 97 | 1.140 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2018 | 127 | 1.120 |
Why?
|
| Calcineurin | 2 | 2024 | 130 | 1.070 |
Why?
|
| Blood Pressure | 5 | 2023 | 1568 | 1.040 |
Why?
|
| Rats | 15 | 2024 | 6441 | 1.020 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2024 | 2156 | 0.930 |
Why?
|
| Calcium Channels, L-Type | 2 | 2021 | 78 | 0.880 |
Why?
|
| Rats, Inbred WKY | 8 | 2023 | 110 | 0.760 |
Why?
|
| Rats, Inbred SHR | 8 | 2023 | 112 | 0.760 |
Why?
|
| Gene-Environment Interaction | 1 | 2021 | 163 | 0.710 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2020 | 64 | 0.680 |
Why?
|
| Orexin Receptors | 1 | 2019 | 2 | 0.680 |
Why?
|
| Presynaptic Terminals | 1 | 2020 | 121 | 0.670 |
Why?
|
| Vasomotor System | 1 | 2019 | 31 | 0.670 |
Why?
|
| Glutamic Acid | 2 | 2020 | 335 | 0.650 |
Why?
|
| Ion Channels | 1 | 2020 | 232 | 0.640 |
Why?
|
| Stress, Psychological | 4 | 2021 | 1043 | 0.620 |
Why?
|
| KCNQ Potassium Channels | 1 | 2016 | 11 | 0.560 |
Why?
|
| Hippocampus | 2 | 2020 | 919 | 0.490 |
Why?
|
| Patch-Clamp Techniques | 4 | 2020 | 398 | 0.490 |
Why?
|
| Stress, Physiological | 1 | 2018 | 486 | 0.480 |
Why?
|
| Corticotropin-Releasing Hormone | 4 | 2018 | 94 | 0.450 |
Why?
|
| Animals | 22 | 2024 | 61956 | 0.430 |
Why?
|
| Solute Carrier Family 12, Member 2 | 2 | 2023 | 13 | 0.360 |
Why?
|
| Membrane Proteins | 1 | 2020 | 2928 | 0.330 |
Why?
|
| Synapses | 2 | 2024 | 546 | 0.280 |
Why?
|
| Obesity | 1 | 2019 | 2904 | 0.270 |
Why?
|
| DNA Demethylation | 1 | 2023 | 11 | 0.230 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2023 | 78 | 0.220 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2020 | 43 | 0.220 |
Why?
|
| Aspartic Acid | 1 | 2023 | 136 | 0.210 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2022 | 8 | 0.210 |
Why?
|
| Corticosterone | 3 | 2017 | 122 | 0.210 |
Why?
|
| Organ Culture Techniques | 2 | 2020 | 229 | 0.200 |
Why?
|
| N-Methylaspartate | 1 | 2022 | 53 | 0.200 |
Why?
|
| Theta Rhythm | 1 | 2021 | 30 | 0.200 |
Why?
|
| Nestin | 1 | 2020 | 42 | 0.180 |
Why?
|
| Posterior Horn Cells | 1 | 2021 | 129 | 0.180 |
Why?
|
| Microinjections | 1 | 2020 | 104 | 0.180 |
Why?
|
| Propionates | 1 | 2020 | 73 | 0.180 |
Why?
|
| Calcium Channels | 2 | 2018 | 213 | 0.180 |
Why?
|
| Long-Term Potentiation | 1 | 2021 | 177 | 0.180 |
Why?
|
| Male | 16 | 2024 | 128315 | 0.180 |
Why?
|
| Orexins | 1 | 2019 | 6 | 0.170 |
Why?
|
| Telemetry | 1 | 2019 | 40 | 0.170 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2020 | 76 | 0.170 |
Why?
|
| Rats, Zucker | 1 | 2019 | 59 | 0.170 |
Why?
|
| Arterial Pressure | 1 | 2019 | 106 | 0.160 |
Why?
|
| Neuronal Plasticity | 1 | 2021 | 326 | 0.160 |
Why?
|
| Spinal Cord | 1 | 2021 | 718 | 0.150 |
Why?
|
| Adrenergic Fibers | 1 | 2017 | 9 | 0.150 |
Why?
|
| Calcium | 1 | 2024 | 1578 | 0.150 |
Why?
|
| Renin-Angiotensin System | 1 | 2018 | 105 | 0.150 |
Why?
|
| Receptors, GABA-B | 1 | 2017 | 31 | 0.140 |
Why?
|
| Neuropeptide Y | 1 | 2017 | 49 | 0.140 |
Why?
|
| Receptors, Ghrelin | 1 | 2017 | 34 | 0.140 |
Why?
|
| Hypoxia | 1 | 2020 | 472 | 0.140 |
Why?
|
| Angiotensin II | 1 | 2018 | 198 | 0.140 |
Why?
|
| Ghrelin | 1 | 2017 | 71 | 0.140 |
Why?
|
| KCNQ3 Potassium Channel | 1 | 2016 | 19 | 0.140 |
Why?
|
| Adenylate Kinase | 1 | 2016 | 36 | 0.140 |
Why?
|
| Behavior, Animal | 1 | 2020 | 747 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 184 | 0.140 |
Why?
|
| Gene Silencing | 1 | 2019 | 827 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2021 | 5728 | 0.130 |
Why?
|
| Heart Rate | 1 | 2019 | 742 | 0.130 |
Why?
|
| Peptides | 1 | 2022 | 1504 | 0.130 |
Why?
|
| Casein Kinase I | 1 | 2015 | 22 | 0.130 |
Why?
|
| Brain Ischemia | 1 | 2018 | 311 | 0.130 |
Why?
|
| Protein Subunits | 1 | 2016 | 278 | 0.130 |
Why?
|
| Neural Inhibition | 1 | 2016 | 152 | 0.120 |
Why?
|
| Neuroendocrine Tumors | 1 | 2021 | 656 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 279 | 0.120 |
Why?
|
| Glucose | 1 | 2020 | 1218 | 0.120 |
Why?
|
| src-Family Kinases | 1 | 2016 | 487 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2019 | 2090 | 0.110 |
Why?
|
| Mice | 4 | 2023 | 35600 | 0.110 |
Why?
|
| Pain | 1 | 2021 | 1694 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 2196 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2018 | 776 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 5056 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 7100 | 0.100 |
Why?
|
| Stroke | 1 | 2018 | 1049 | 0.090 |
Why?
|
| Brain | 1 | 2023 | 4208 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 5776 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 7265 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5257 | 0.050 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2021 | 28 | 0.050 |
Why?
|
| Sciatic Nerve | 1 | 2021 | 120 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2021 | 282 | 0.040 |
Why?
|
| Tetrazolium Salts | 1 | 2018 | 49 | 0.040 |
Why?
|
| Agouti-Related Protein | 1 | 2017 | 50 | 0.040 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2017 | 50 | 0.040 |
Why?
|
| Bumetanide | 1 | 2016 | 8 | 0.030 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2016 | 12 | 0.030 |
Why?
|
| Muscimol | 1 | 2016 | 15 | 0.030 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2016 | 7 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 220 | 0.030 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2017 | 103 | 0.030 |
Why?
|
| Proteomics | 1 | 2024 | 1427 | 0.030 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2016 | 31 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 1655 | 0.030 |
Why?
|
| Receptors, GABA-A | 1 | 2016 | 81 | 0.030 |
Why?
|
| Female | 3 | 2021 | 148940 | 0.030 |
Why?
|
| DNA | 1 | 2023 | 3050 | 0.030 |
Why?
|
| Eating | 1 | 2017 | 448 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2016 | 436 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2023 | 6390 | 0.030 |
Why?
|
| Pyridazines | 1 | 2016 | 324 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3035 | 0.030 |
Why?
|
| Humans | 4 | 2024 | 270740 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 3584 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2016 | 2422 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 4223 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 7783 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 7381 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 90352 | 0.010 |
Why?
|